MX2019001380A - Cristales de derivado de amina ciclica y uso farmaceutico de los mismos. - Google Patents
Cristales de derivado de amina ciclica y uso farmaceutico de los mismos.Info
- Publication number
- MX2019001380A MX2019001380A MX2019001380A MX2019001380A MX2019001380A MX 2019001380 A MX2019001380 A MX 2019001380A MX 2019001380 A MX2019001380 A MX 2019001380A MX 2019001380 A MX2019001380 A MX 2019001380A MX 2019001380 A MX2019001380 A MX 2019001380A
- Authority
- MX
- Mexico
- Prior art keywords
- crystals
- ciclica
- amina
- derivative
- same
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 4
- QUTKDCYSTKFFEU-LBPRGKRZSA-N (3S)-1-[4-(dimethylamino)piperidin-1-yl]-3-hydroxy-3-(1-methylimidazol-2-yl)propan-1-one Chemical compound CN(C1CCN(CC1)C(C[C@@H](C=1N(C=CN=1)C)O)=O)C QUTKDCYSTKFFEU-LBPRGKRZSA-N 0.000 abstract 1
- 208000001640 Fibromyalgia Diseases 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
El propósito de la presente invención es proporcionar cristales de un compuesto que exhiba una acción analgésica contra el dolor neuropático y/o el síndrome de fibromialgia, los cristales siendo útiles como productos farmacéuticos. La presente invención proporciona cristales de (S)-1-(4-(dimetilamino)piperidin-1-il)-3- hidroxi-3-(1-metil-1H-imidazol-2-il)propan-1-ona o una sal farmacológicamente aceptable de los mismos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016165437 | 2016-08-26 | ||
| PCT/JP2017/030528 WO2018038255A1 (ja) | 2016-08-26 | 2017-08-25 | 環状アミン誘導体の結晶及びその医薬用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019001380A true MX2019001380A (es) | 2019-05-20 |
| MX379181B MX379181B (es) | 2025-03-11 |
Family
ID=61244990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019001380A MX379181B (es) | 2016-08-26 | 2017-08-25 | Cristales de derivado de amina ciclica y uso farmaceutico de los mismos. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10961217B2 (es) |
| EP (1) | EP3505515B1 (es) |
| JP (1) | JP6610793B2 (es) |
| KR (1) | KR102235994B1 (es) |
| CN (1) | CN109563072B (es) |
| AU (1) | AU2017314560B2 (es) |
| CA (1) | CA3035161C (es) |
| DK (1) | DK3505515T3 (es) |
| ES (1) | ES2905733T3 (es) |
| HU (1) | HUE057370T2 (es) |
| IL (1) | IL264673B (es) |
| MX (1) | MX379181B (es) |
| PH (1) | PH12019500287A1 (es) |
| PL (1) | PL3505515T3 (es) |
| PT (1) | PT3505515T (es) |
| RU (1) | RU2719384C1 (es) |
| SA (1) | SA519401004B1 (es) |
| TW (1) | TWI702210B (es) |
| WO (1) | WO2018038255A1 (es) |
| ZA (1) | ZA201901263B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6800492B2 (ja) * | 2018-06-29 | 2020-12-16 | ＭｉＺ株式会社 | 水素を含む癌性疼痛の抑制もしくは軽減のための組成物 |
| CN111039984B (zh) * | 2018-10-15 | 2022-06-07 | 上海盟科药业股份有限公司 | 康泰唑胺酯的药物晶体及其制备方法和应用 |
| CA3123833A1 (en) * | 2018-12-26 | 2020-07-02 | Toray Industries, Inc. | Cyclic amine derivative as agent for promoting advillin function, and novel cyclic amine derivative and pharmaceutical use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6137765A (ja) * | 1984-07-19 | 1986-02-22 | サンド・アクチエンゲゼルシヤフト | ３‐アミノプロポキシアリール誘導体 |
| DE3524955A1 (de) * | 1984-07-19 | 1986-01-30 | Sandoz-Patent-GmbH, 7850 Lörrach | 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel |
| GB2163150B (en) | 1984-07-19 | 1988-05-25 | Sandoz Ltd | 3-aminopropoxyaryl derivatives |
| JP2567885Y2 (ja) | 1991-03-15 | 1998-04-08 | ソニー株式会社 | ビデオモニタ装置 |
| US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
| JP4563675B2 (ja) | 2001-10-12 | 2010-10-13 | ハイ・ポイント・ファーマスーティカルズ、エルエルシー | 置換ピペリジン類、およびヒスタミンｈ３受容体関連疾患の治療のためのその使用 |
| FR2862647B1 (fr) * | 2003-11-25 | 2008-07-04 | Aventis Pharma Sa | Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant |
| JP2006008664A (ja) | 2004-05-21 | 2006-01-12 | Takeda Chem Ind Ltd | イミダゾール誘導体、その製造法及び用途 |
| WO2013147160A1 (ja) * | 2012-03-29 | 2013-10-03 | 東レ株式会社 | 環状アミン誘導体及びその医薬用途 |
| TWI652264B (zh) * | 2013-09-26 | 2019-03-01 | 東麗股份有限公司 | Cyclic amine derivatives and their medical uses |
| MX2017010624A (es) | 2015-02-27 | 2017-12-07 | Toray Industries | Derivado de amina ciclica y su uso farmaceutico. |
| JP6767011B2 (ja) * | 2015-09-18 | 2020-10-14 | ヤマサ醤油株式会社 | 抗ｄｎａウィルス活性などの生理活性を有するヌクレオシド誘導体 |
-
2017
- 2017-08-25 HU HUE17843731A patent/HUE057370T2/hu unknown
- 2017-08-25 ES ES17843731T patent/ES2905733T3/es active Active
- 2017-08-25 CN CN201780051578.1A patent/CN109563072B/zh active Active
- 2017-08-25 WO PCT/JP2017/030528 patent/WO2018038255A1/ja not_active Ceased
- 2017-08-25 DK DK17843731.5T patent/DK3505515T3/da active
- 2017-08-25 JP JP2018535784A patent/JP6610793B2/ja active Active
- 2017-08-25 EP EP17843731.5A patent/EP3505515B1/en active Active
- 2017-08-25 MX MX2019001380A patent/MX379181B/es unknown
- 2017-08-25 PL PL17843731T patent/PL3505515T3/pl unknown
- 2017-08-25 CA CA3035161A patent/CA3035161C/en active Active
- 2017-08-25 RU RU2019108061A patent/RU2719384C1/ru active
- 2017-08-25 PT PT178437315T patent/PT3505515T/pt unknown
- 2017-08-25 US US16/326,580 patent/US10961217B2/en active Active
- 2017-08-25 AU AU2017314560A patent/AU2017314560B2/en active Active
- 2017-08-25 KR KR1020197005849A patent/KR102235994B1/ko active Active
- 2017-08-25 TW TW106128883A patent/TWI702210B/zh active
-
2019
- 2019-01-31 SA SA519401004A patent/SA519401004B1/ar unknown
- 2019-02-05 IL IL26467319A patent/IL264673B/en active IP Right Grant
- 2019-02-11 PH PH12019500287A patent/PH12019500287A1/en unknown
- 2019-02-27 ZA ZA2019/01263A patent/ZA201901263B/en unknown
-
2021
- 2021-02-10 US US17/172,240 patent/US11834431B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10961217B2 (en) | 2021-03-30 |
| EP3505515A4 (en) | 2020-02-12 |
| ES2905733T3 (es) | 2022-04-11 |
| IL264673B (en) | 2019-11-28 |
| AU2017314560A1 (en) | 2019-02-21 |
| MX379181B (es) | 2025-03-11 |
| ZA201901263B (en) | 2021-06-30 |
| EP3505515B1 (en) | 2021-11-24 |
| US20210198236A1 (en) | 2021-07-01 |
| DK3505515T3 (da) | 2022-01-24 |
| CA3035161A1 (en) | 2018-03-01 |
| WO2018038255A1 (ja) | 2018-03-01 |
| PL3505515T3 (pl) | 2022-04-04 |
| JPWO2018038255A1 (ja) | 2019-02-28 |
| CN109563072A (zh) | 2019-04-02 |
| SA519401004B1 (ar) | 2021-10-06 |
| PT3505515T (pt) | 2022-02-11 |
| US20200172507A1 (en) | 2020-06-04 |
| TW201808932A (zh) | 2018-03-16 |
| TWI702210B (zh) | 2020-08-21 |
| KR20190034609A (ko) | 2019-04-02 |
| KR102235994B1 (ko) | 2021-04-05 |
| RU2719384C1 (ru) | 2020-04-17 |
| US11834431B2 (en) | 2023-12-05 |
| HUE057370T2 (hu) | 2022-05-28 |
| PH12019500287A1 (en) | 2019-10-28 |
| CN109563072B (zh) | 2021-05-11 |
| CA3035161C (en) | 2025-07-08 |
| AU2017314560B2 (en) | 2021-06-03 |
| JP6610793B2 (ja) | 2019-11-27 |
| EP3505515A1 (en) | 2019-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2020000102A (es) | Compuestos útiles para inhibir a cdk7 | |
| CY1119767T1 (el) | Παραγωγα πιπεριδινυλικης ινδολης και η χρηση τους ως αναστολεις του παραγοντα β του συμπληρωματος | |
| MX2020010737A (es) | Derivados de sulfamoilarilamida ciclados y su uso como medicamentos para el tratamiento de la hepatitis b. | |
| MX383686B (es) | Derivados de piridazina 1,4-disustituida, y su uso para el tratamiento de afecciones relacionadas con la deficiencia de smn. | |
| GT201600085A (es) | Composiciones y métodos para modular los receptores x farnesoides | |
| DOP2016000085A (es) | Amino-heteroaril-benzamidas como inhibidores de cinasa | |
| MX386826B (es) | Compuestos de triazolopiridina y métodos para el tratamiento de fibrosis cística | |
| CR20150628A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
| CL2016002970A1 (es) | Sales de adición de (s)-2-(1-(6-amino-5-cianopirimidin-4-ilamino)etil)-4-oxo-3-fenil-3,4-dihidropirrolo[1,2-f][1,2,4]triazina-5-carbonitrilo. | |
| ECSP16005566A (es) | Sulfonamidas como moduladores de canales de sodio | |
| GT201600070A (es) | Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
| CR20160191A (es) | Compuestos derivados de piridilo bicíclicos fusionados a anillo como inhibidores de fgfr4 | |
| CU20160188A7 (es) | Compuestos de indazole substituidos como inhibidores de irak4 | |
| GT201700023A (es) | Derivados de heterociclico opcionalmente condensados de piridimina útiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncológicas y autoinmunitarias | |
| PH12017501297B1 (en) | Cyclic amine derivative and pharmaceutical use thereof | |
| UY37837A (es) | Nuevos compuestos heterocíclicos como inhibidores de cdk8/19 | |
| UY36124A (es) | Derivados de carboxamida | |
| UY36123A (es) | Derivados de carboxamida | |
| ECSP19013196A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| CL2020001277A1 (es) | Derivados de piridinona y su uso como inhibidores selectivos de alk-2. | |
| MX2019001380A (es) | Cristales de derivado de amina ciclica y uso farmaceutico de los mismos. | |
| EA201591259A1 (ru) | Твёрдые формы производного хиназолина и их применение в качестве ингибитора braf | |
| MX2019010485A (es) | Derivado de amina ciclica y uso farmaceutico del mismo. | |
| MX2019010108A (es) | Derivados de azetidina. | |
| AR132461A2 (es) | Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos |